loadpatents
name:-0.010890960693359
name:-0.0070710182189941
name:-0.0026960372924805
Scheurich; Peter Patent Filings

Scheurich; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Scheurich; Peter.The latest application filed is for "monovalent inhibitor of hutnfr1 interaction".

Company Profile
2.9.7
  • Scheurich; Peter - Stuttgart DE
  • Scheurich; Peter - Remlingen N/A DE
  • Scheurich; Peter - Stuutgart DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof
Grant 10,689,452 - Kontermann , et al.
2020-06-23
MONOVALENT INHIBITOR OF huTNFR1 INTERACTION
App 20190144555 - KONTERMANN; Roland ;   et al.
2019-05-16
huTNFR1 selective antagonists
Grant 9,045,535 - Pfizenmaier , et al. June 2, 2
2015-06-02
Recombinant polypeptides of the members of the TNF ligand family and use thereof
Grant 8,927,205 - Pfizenmaier , et al. January 6, 2
2015-01-06
Method for producing a toothbrush head
Grant 8,651,582 - Driesen , et al. February 18, 2
2014-02-18
huTNFR1 SELECTIVE ANTAGONISTS
App 20130244341 - PFIZENMAIER; Klaus ;   et al.
2013-09-19
huTNFR1 selective antagonists
Grant 8,404,238 - Pfizenmaier , et al. March 26, 2
2013-03-26
Method For Producing A Toothbrush Head
App 20120019046 - Driesen; Georges ;   et al.
2012-01-26
huTNFR1 Selective Antagonists
App 20100150916 - Pfizenmaier; Klaus ;   et al.
2010-06-17
Nanoparticles comprising biologically active TNF which is immobilized on the same
Grant 7,368,295 - Tovar , et al. May 6, 2
2008-05-06
Recombinant Polypeptides of the Members of the Tnf Ligand Family and Use Thereof
App 20070286843 - Pfizenmaier; Klaus ;   et al.
2007-12-13
Nanoparticles comprising biologically active tnf which is immobilized on the same
App 20040265392 - Tovar, Gunter ;   et al.
2004-12-30
Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
App 20040053829 - Pfizenmaier, Klaus ;   et al.
2004-03-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed